Insmed Overview
Insmed Target Price
Analysts' 12-month price predictions for INSM.
Share Price
$65.71
Average Target Price
$110.00
67.4% upside
67.4% upside1 analysts in the last 4 months
High: $110 | Low: $110
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-06 | UBS | $110 | 67.4% upside |  |
| 2024-08-15 | Mizuho SecuritiesGraig Suvannavejh | $92 | 40% upside | |
| 2024-08-09 | Wells FargoTiago Fauth | $85 | 29.4% upside | |
| 2024-07-09 | GuggenheimVamil Divan | $95 | 44.6% upside | |
| 2024-07-01 | Truist FinancialNicole Germino | $88 | 33.9% upside | |
| 2024-06-25 | BarclaysLeon Wang | $90 | 37% upside | |
| 2024-06-21 | Evercore ISILiisa Bayko | $75 | 14.1% upside | |
| 2024-06-07 | Mizuho SecuritiesGraig Suvannavejh | $82 | 24.8% upside | |
| 2024-06-05 | Stifel NicolausStephen Willey | $74 | 12.6% upside | |
| 2024-05-29 | Wells FargoTiago Fauth | $77 | 17.2% upside | |
| 2024-05-29 | H.C. WainwrightAndrew Fein | $70 | 6.5% upside | |
| 2024-05-29 | UBSTrung Huynh | $58 |  11.7% downside | |
| 2024-05-29 | Truist FinancialNicole Germino | $68 | 3.5% upside | |
| 2024-05-29 | Wolfe ResearchAndy Chen | $54 | 17.8% downside | |
| 2024-05-28 | Morgan StanleyJeffrey Hung | $60 | 8.7% downside | |
| 2024-05-28 | Goldman SachsAndrea Tan | $74 | 12.6% upside | |
| 2024-05-28 | Evercore ISILiisa Bayko | $42 | 36.1% downside | |
| 2024-05-13 | Mizuho SecuritiesGraig Suvannavejh | $36 | 45.2% downside | |
| 2024-05-09 | Morgan StanleyJeffrey Hung | $43 | 34.6% downside | |
| 2024-04-23 | Truist FinancialNicole Germino | $48 | 27% downside | |
| 2024-04-01 | Wells FargoTiago Fauth | $55 | 16.3% downside | |
| 2022-04-27 | Goldman Sachs | $56 | 14.8% downside | |